Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
VERV | Verve Therapeutics, Inc. | 10%+ Owner | $4.1M | Jun 16, 2021 | ||
STOK | Stoke Therapeutics, Inc. | Chief Medical Officer | $663K | -$1.28M | -65.9% | Nov 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|